A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: A gynecologic oncology group trial

  • Russell J. Schilder
  • , John A. Blessing
  • , Mark S. Shahin
  • , David S. Miller
  • , Krishnansu Sujata Tewari
  • , Carolyn Y. Muller
  • , David P. Warshal
  • , Scott McMeekin
  • , Jacob Rotmensch

Research output: Contribution to journalArticlepeer-review

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)1137-1141
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume20
Issue number7
DOIs
StatePublished - Oct 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this